EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Revealing the clinical relevance of Staphylococcus borealis

Jorunn Pauline Cavanagh iD, Claus Klingenberg, Hermoine Jean Venter, Jan Egil Afset, Olaf Stromme, Paul Christoffer Lindemann, Therese Johansen, Kyriakos Zaragkoulias, Hege Vangstein Aamot, Ståle Tofteland, Pia Littauer

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.01988-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Jorunn Pauline Cavanagh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Research Group for Child and Adolescent Health, UiT-The Arctic University of Norway, Tromsø, Norway. Hauptthemen laut MEDLINE: Staphylococcus, Staphylococcal Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse Nord RHF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus borealis , previously misidentified as Staphylococcus haemolyticus , was first described as a new species in 2020. In this study, we aimed to describe the clinical relevance of S. borealis by combining clinical data, antibiotic susceptibility profiles, and biofilm formation in isolates obtained from hospitalized and non-hospitalized patients. We established a collection of 129 S . borealis isolates from 129 adult patients from seven Norwegian hospitals. We describe clinical data at the time of microbiological specimen collection. Antibiotic susceptibility and biofilm formation were tested using established methods. Of 129 isolates (37%), 48 were from patients admitted to a hospital, the remaining from outpatients. The median (IQR) age was 62 (51–78) years, and 85/129 (66%) of the isolates were from male patients. The majority (81/129, 63%) of the S. borealis isolates were isolated from urine cultures, followed by isolation from skin and soft tissue cultures (35/129, 27%), blood cultures (8/129, 6%), and two implant-associated infections (2/129, 2%). Resistance to ≥3 antibiotic classes was observed in 43/129 (33%) of the isolates. All isolates formed a biofilm under the conditions tested; 59/129 (46%) weak, 40/129 (31%) medium, and 29/129 (23%) were strong biofilm producers. S. borealis clinical samples were predominately obtained from elderly male patients, and the majority of samples were from patients with suspected urinary tract or skin and soft tissue infections. The level of multidrug resistance was comparable to other coagulase-negative staphylococcal species, but resistance toward methicillin and penicillin was lower than in clinical S. haemolyticus isolates. IMPORTANCE This study contributes novel knowledge on the clinical relevance of Staphylococcus borealis ; this is of importance when clinical microbiologists encounter S. borealis identified in patient samples. S. borealis was mainly identified in microbiological specimens from middle-aged to elderly patients, predominantly males. Hospitalized patients were also frequently immunocompromised and had other underlying conditions accompanying a suspected S. borealis infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StaphylococcusStaphylococcal InfectionsHumansMaleMiddle AgedAgedAnti-Bacterial AgentsMicrobial Sensitivity TestsFemaleBiofilmsNorwayDrug Resistance, Multiple, BacterialClinical Relevance

Stichwörter der Autor:innen

Staphylococcus borealisbiofilm formationclinical relevancemultidrug resistanceskin and soft tissue infectionsurinary tract infections

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Clinical Medicine, Research Group for Child and Adolescent Health, UiT-The Arctic University of Norway, Tromsø, Norway.
  • Center for New Antibacterial Strategies, UiT-The Arctic University of Norway, Tromsø, Norway.
  • Department of Pediatrics, University Hospital of North Norway, Tromsø, Norway.
  • St. Olavs University Hospital, Trondheim, Norway.
  • Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
  • Department of Microbiology, Haukeland University Hospital, Bergen, Norway.

ORCID-Profile: Jorunn Pauline Cavanagh

Förderung

  • Helse Nord RHF

Zitieren

APA

Cavanagh, J. P., Klingenberg, C., Venter, H. J., Afset, J. E., Stromme, O., Lindemann, P. C., Johansen, T., Zaragkoulias, K., Aamot, H. V., Tofteland, S., & Littauer, P. (2025). Revealing the clinical relevance of Staphylococcus borealis. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01988-24

Vancouver

Cavanagh JP, Klingenberg C, Venter HJ, Afset JE, Stromme O, Lindemann PC, et al. Revealing the clinical relevance of Staphylococcus borealis. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01988-24

BibTeX
@article{Cavanagh2025,
  author = {Cavanagh, Jorunn Pauline and Klingenberg, Claus and Venter, Hermoine Jean and Afset, Jan Egil and Stromme, Olaf and Lindemann, Paul Christoffer and Johansen, Therese and Zaragkoulias, Kyriakos and Aamot, Hege Vangstein and Tofteland, Ståle and Littauer, Pia},
  title = {Revealing the clinical relevance of Staphylococcus borealis},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.01988-24}
}
Kostenlos starten →